Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Papillomavirus Infections 7Uterine Cervical Neoplasms 5Neuroendocrine Tumors 4Neoplasms 4Autoimmune Diseases 3Ovarian Neoplasms 2Myasthenia Gravis 2Mesothelioma, Malignant 2Lung Neoplasms 2Venous Thrombosis 1Venous Thromboembolism 1Uterine Cervical Dysplasia 1Thyroid Diseases 1Thrombosis 1Squamous Intraepithelial Lesions 1Retinal Telangiectasis 1Renal Insufficiency 1Recurrence 1Prostatic Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Mesothelioma 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphohistiocytosis, Hemophagocytic 1Leukemia, Hairy Cell 1Hemorrhage 1Hematologic Neoplasms 1Glioma 1Glioblastoma 1

Interventions

apixaban 3Warfarin 2Dalteparin 2Aspirin 2salicylhydroxamic acid 1fluorescein isothiocyanate-keyhole limpet hemocyanin 1edoxaban 1Simvastatin 1Rivaroxaban 1Radiotherapy, Conformal 1Paclitaxel 1Observation 1Injections 1Fondaparinux 1Enoxaparin 1Docetaxel 1Data Collection 1Dabigatran 1Clopidogrel 1Arginine Vasopressin 1Arginine 1Anticoagulants 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Thrombosis × Data Collection × Clear all
NCT04846556 2023-10-11

Cancer Associated Thrombosis : What is the Proportion of Patients Ineligible to a Study as CARAVAGGIO

Centre Hospitalier Universitaire de Saint Etienne

Completed
300 enrolled
Classical hematology

Neoplasms, Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡